SS Lynch, CM Cheng - Annals of Pharmacotherapy, 2007 - Harvey Whitney Books Low vision and blindness, respectively, affect an estimated 2.4 million Amer-
icans and 937 000 of those over the age of 40 years. It is expected that 5.5
mil- lion Americans will be affected by these conditions by the year 2020. ... Cited by 49 - Related articles - BL Direct - All 4 versions
F Gomi, M Sawa, H Sakaguchi, M Tsujikawa, … - British Medical Journal, 2008 - bjo.bmj.com Results: At baseline, subretinal fluid was observed in five eyes and a pigment
epithelial detachment in eight eyes. The foveal height 1 month after injection
decreased significantly (p = 0.023), but at 3 months, no significant ... Cited by 26 - Related articles - BL Direct - All 4 versions
C Shima, H Sakaguchi, F Gomi, M Kamei, Y … - Acta Ophthalmologica, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 24 - Related articles - BL Direct - All 3 versions
F Gomi, K Nishida, Y Oshima, H Sakaguchi, … - American journal of ophthalmology, 2007 - Elsevier After treatment, the BCVA improvement at one month (P = .029) continued to three
months (P = .003). CRT decreased significantly (P < .001). Leakage from
idiopathic CNV three months after treatment stopped in seven eyes, ... Cited by 19 - Related articles - All 11 versions
- ►duanesolution.com IA FALKENSTEIN, L Cheng, VL MORRISON, … - Retina, 2007 - journals.lww.com IRYNA A. FALKENSTEIN, MD, LINGYUN CHENG, MD, VICTORIA L. MORRISON, MD, IGOR
KOZAK, MD, AJAY M. TAMMEWAR, MD, WILLIAM R. FREEMAN, MD ... Purpose: To compare
standardized visual outcomes and macular thickness changes associated with ... Cited by 18 - Related articles - BL Direct - All 6 versions
JM Ruiz-Moreno, F Gomez-Ulla, JA Montero, S … - Eye, 2009 - phx1.medscape.com New antiangiogenic drugs have been made available to treat subfoveal CNV
secondary to high myopia, although there have not been too many reports yet.
[11-20] The purpose of this pilot study is to evaluate the outcome of ... Cited by 16 - Related articles - All 8 versions
- ►prsjournal.com [PDF] L Arias, N Planas, S Prades, JM Caminal, M … - British Medical Journal, 2008 - bjo.bmj.com Results: There were 17 eyes of 17 patients, and the mean age was 55.4 (SD 10.0)
years. At the 6-month follow-up, the mean visual acuity improved by 8.4 letters
(p = 0.04). Forty-one per cent of patients increased at least one line, and ... Cited by 16 - Related articles - All 5 versions
- ►prsjournal.com RM Silva, JM Ruiz-Moreno, J Nascimento, A … - Retina, 2008 - pdfs.journals.lww.com A significant reduction in ocular coherence tomography central thickness was
observed at 1, 3, and 6 months. No cases of severe visual acuity loss occurred,
and no systemic or ocular side effects were registered during the ... Cited by 13 - Related articles - All 5 versions
S Mandal, P Venkatesh, Z Abbas, R Vohra, S … - Graefe's Archive for Clinical and Experimental …, 2007 - Springer Abstract Background To evaluate the efficacy and safety of intra- vitreal
bevacizumab (Avastin) in the treatment of subretinal neovascularization (SRNV)
secondary to type 2A idiopath- ic juxtafoveal telangiectasia (IJT). Methods ... Cited by 12 - Related articles - BL Direct - All 2 versions
